Trials / Completed
CompletedNCT02861287
Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to realize an economic evaluation of the introduction of Plerixafor in addition to G-CSF and alternative options, in patients with multiple myeloma (MM) who failed or insufficiently mobilize peripheral blood stem and progenitor cells in response to G-CSF alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Economic evaluation |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- First posted
- 2016-08-10
- Last updated
- 2016-08-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02861287. Inclusion in this directory is not an endorsement.